Loading…

Browse All Grants

20,252 grants found

Filters
Reset

Showing 1,9411,960 of 20,252 grants

Completed NON-SBIR/STTR RPGS
Therapeutic targeting of VHL-deficient clear cell renal cell carcinoma
NATIONAL CANCER INSTITUTE University of California-Irvine United States 2024 – 2025

Project Summary/Abstract Synthetic lethality screens hold great promise for cancer therapy since they enable the identification of chemical compounds that selectively target tumor...

$1.73M
USD
Completed NON-SBIR/STTR RPGS
The molecular basis of 7SK RNA methylation in non-small cell lung cancer
NATIONAL CANCER INSTITUTE University of Florida United States 2024 – 2025

PROJECT SUMMARY Lung cancer is a leading cause of cancer death in the United States, with non-small cell lung cancer (NSCLC) being the major subtype accounting for approximately 85...

$1.78M
USD
Completed NON-SBIR/STTR RPGS
Calcium metabolism and lung cancer preneoplasia
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2025

PROJECT SUMMARY/ABSTRACT Lung cancer is the second deadliest cancer. Despite its prevalence and unfavorable consequences, current therapeutic approaches are limited. The proposed s...

$810K
USD
Completed NON-SBIR/STTR RPGS
A sensitivity analysis framework for generalizing randomized clinical trial results in the presence of unmeasured treatment effect modifiers
NATIONAL CANCER INSTITUTE Ohio State University United States 2024 – 2025

ABSTRACT Randomized controlled trials (RCTs) are the gold standard for assessing interventions for preventing and treating cancer, but their external validity is only guaranteed if...

$907.2K
USD
Completed NON-SBIR/STTR RPGS
Novel approaches to enrich CAR-T cell Therapy in brain tumors using focused ultrasound
NATIONAL CANCER INSTITUTE University of North Carolina Chapel Hill United States 2024 – 2025

PROJECT SUMMARY Focused Ultrasound (FUS) is a powerful technology now FDA approved for several ablative brain therapies, and has demonstrated an impressive safety and efficacy prof...

$1.75M
USD
Completed NON-SBIR/STTR RPGS
Profiling Epitranscriptomic RNA editing in Pediatric Cancer
NATIONAL CANCER INSTITUTE University of California, San Diego United States 2024 – 2025

SUMMARY/ABSTRACT Relapsed pediatric T-cell acute lymphoblastic leukemia (T-ALL) is often refractory to conventional therapy and is associated with a dismal survival rate of less th...

$1.58M
USD
Completed OTHER RESEARCH-RELATED
Identifying and examining the effects of source and presentation on responses to electronic cigarette public education messages in young adult vapers and non-vapers
NATIONAL CANCER INSTITUTE University of Massachusetts Med Sch Worc... United States 2024 – 2025

PROJECT SUMMARY E-cigarette use (vaping) in 18-24-year-olds is a public health crisis. It is an urgent public health priority to communicate to young adults about the health harm o...

$1.52M
USD
Completed NON-SBIR/STTR RPGS
TAZ-driven Regulation of Tumor Microenvironment in Triple-Negative Breast Cancer
NATIONAL CANCER INSTITUTE Roswell Park Cancer Institute Corp United States 2024 – 2024

ABSTRACT Breast cancer (BC) is a complex and heterogeneous neoplastic disease with a high incidence and mortality. BC can be divided into clinical, histopathologic, and molecular s...

$375.5K
USD
Completed NON-SBIR/STTR RPGS
Regulation of esophageal tumorigenesis by protein adduction
NATIONAL CANCER INSTITUTE University of Miami School of Medicine United States 2024 – 2025

SUMMARY Esophageal adenocarcinoma (EAC) is the most prevalent histological type of esophageal malignancy in the US and many Western nations. This tumor remains deadly as approximat...

$767.5K
USD
Completed NON-SBIR/STTR RPGS
Mechanisms of Resistance and Therapeutic Targets in T-LGL Leukemia
NATIONAL CANCER INSTITUTE Ohio State University United States 2024 – 2025

ABSTRACT T-cell large granular lymphocytic leukemia (T-LGLL) is an incurable, underdiagnosed proliferation of clonal CD8+ cytotoxic T-lymphocytes that results in severe neutropenia...

$787.5K
USD
Active NON-SBIR/STTR RPGS
Is ERBB4 a Driver of BRAF WT Melanomas?
NATIONAL CANCER INSTITUTE Auburn University At Auburn United States 2024 – 2026

Combining immune checkpoint inhibitors with BRAF and MEK inhibitors has enabled significant improvements in treating metastatic skin cutaneous melanomas that possess activating mut...

$4.51M
USD
Completed OTHER RESEARCH-RELATED
Quantitative modeling of extrachromosomal DNA (ecDNA) evolution in tumors
NATIONAL CANCER INSTITUTE Stanford University United States 2024 – 2025

Project Summary. Cancer is governed by evolutionary principles whereby sequential changes at the genetic and epigenetic level enable proliferation, immune evasion, drug resistance,...

$1.68M
USD
Completed OTHER RESEARCH-RELATED
Learning about the effectiveness of lung cancer screening in real-world target populations
NATIONAL CANCER INSTITUTE Harvard School of Public Health United States 2024 – 2025

PROJECT SUMMARY/ABSTRACT Even the largest lung cancer screening trial to date, the National Lung Cancer Screening Trial (NLST) is insufficient on its own to answer questions about...

$1.29M
USD
Active NON-SBIR/STTR RPGS
Dissecting Convergent Somatic and Germline Alterations that Mediate the Origins and Evolution of Kidney Cancer
NATIONAL CANCER INSTITUTE Dana-Farber Cancer Inst United States 2024 – 2028

PROJECT SUMMARY Germline pathogenic mutations and common variants have been implicated in the development of clear cell renal cell carcinoma (ccRCC). Similarly, recurrent somatic a...

$7.29M
USD
Active NON-SBIR/STTR RPGS
Comparative Effectiveness of Sequential Pharmacotherapeutic Strategies and Virtually Delivered Treatment to Optimize Smoking Cessation
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2028

PROJECT SUMMARY There is a critical need for treatment approaches that conveniently deliver evidence-based interventions of counseling and pharmacotherapy to a wide range of smoker...

$9.23M
USD
Active NON-SBIR/STTR RPGS
Notch ligands as oncogenic drivers and therapeutic targets in T-cell lymphomas
NATIONAL CANCER INSTITUTE University of Michigan At Ann Arbor United States 2024 – 2028

Peripheral T-cell lymphomas (PTCL), derived from mature T cells, are aggressive malignancies for which existing therapies are suboptimal, as the median overall survival of patients...

$6.56M
USD
Active NON-SBIR/STTR RPGS
Control of cancer cachexia via stimulation of resolution of inflammation
NATIONAL CANCER INSTITUTE Beth Israel Deaconess Medical Center United States 2024 – 2028

PROJECT SUMMARY While cancer cachexia is a devastating syndrome characterized by progressive muscle wasting, inflammation, and metabolic disruption, the underlying mechanisms remai...

$7.1M
USD
Active NON-SBIR/STTR RPGS
CRACD-controlled cell plasticity and small cell lung cancer
NATIONAL CANCER INSTITUTE University of Tx Md Anderson Can Ctr United States 2024 – 2028

PROJECT SUMMARY/ABSTRACT Small cell lung cancer (SCLC) is an extremely deadly cancer, and current chemo/radiation therapies lack durable effects. Immunotherapy with immune checkpoi...

$6M
USD
Active NON-SBIR/STTR RPGS
Regulation and tumorigenesis of non-classical RAS oncoproteins - Resubmission
NATIONAL CANCER INSTITUTE New York University School of Medicine United States 2024 – 2028

PROJECT SUMMARY Oncoproteins drive tumor development and aggressive growth by dysregulating the signaling pathways involved in cell growth, survival, and proliferation. Targeting o...

$5.44M
USD
Active NON-SBIR/STTR RPGS
Context dependent tumor suppression
NATIONAL CANCER INSTITUTE University of Pennsylvania United States 2024 – 2028

Project Summary We have identified a novel mode of autonomous programmed cell death that is controlled by p53 in small cell lung cancer (SCLC) — the most deadly form of lung cancer...

$4.55M
USD